Not checkedNot checked for notices yet.
IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells
Wan-Chen Hsieh, Tzu-Sheng Hsu, Ya-Jen Chang and 1 more
Nature Communications · 2018
doi:10.1038/s41467-018-02862-4 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
XLP-2 syndrome is caused by XIAP mutation. Here the authors show that mouse and human XIAP-deficient regulatory T cells have defective suppressive function as a result of conversion to proinflammatory cytokine producing cells, an effect that can be prevented by blocking the IL-6 receptor.
Abstract licence: CC BY-NC-ND
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.